TargetMol

Rotigotine

Product Code:
 
TAR-T9237
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T9237-5mg5mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9237-1mL1 mL * 10 mM (in DMSO)£120.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9237-10mg10mg£127.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9237-25mg25mg£161.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9237-50mg50mg£205.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9237-100mg100mg£270.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Rotigotine is an antiparkinson agent and dopamine receptor agonist.
CAS:
92206-54-7
Formula:
C19H25NOS
Molecular Weight:
315.47
Pathway:
GPCR/G Protein; Neuroscience
Purity:
0.98
SMILES:
CCCN(CCc1cccs1)C(CC1)Cc2c1c(O)ccc2
Target:
Dopamine Receptor

References

Frampton J E . Rotigotine Transdermal Patch: A Review in Parkinson's Disease[J]. CNS Drugs, 2019, 33(2):1-12. Kang H, Yu H, Fan J, et al. Rotigotine protects against oxidized low-density lipoprotein (ox-LDL)-induced damages in human umbilical vein endothelial cells (HUVECs). Bioengineered. 2021, 12(2): 10568-10579. Chen F , Jin L , Nie Z . Safety and Efficacy of Rotigotine for Treating Parkinson's Disease: A Meta-Analysis of Randomised Controlled Trials[J]. Journal of Pharmacy & Pharmaceutical Sciences, 2017, 20:285-.